Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Phillip O. Coffin, Rebecca S. Martinez, Brian Wylie & Bunny Ryder. (2022) Primary care management of Long-Term opioid therapy. Annals of Medicine 54:1, pages 2450-2468.
Read now
Read now
Chin Hwa Dahlem, Matthew Myers, Jason Goldstick, James G. Stevenson, George Gray, Sarah Rockhill, Aaron Dora-Laskey, Joan Kellenberg, Chad M. Brummett & Keith E. Kocher. (2022) Factors associated with naloxone availability and dispensing through Michigan’s pharmacy standing order. The American Journal of Drug and Alcohol Abuse 48:4, pages 454-463.
Read now
Read now
Bryon Adinoff & Ziva D. Cooper. (2019) Cannabis legalization: progress in harm reduction approaches for substance use and misuse. The American Journal of Drug and Alcohol Abuse 45:6, pages 707-712.
Read now
Read now
Jessica L. Taylor, Alison B. Rapoport, Christopher F. Rowley, Kenneth J. Mukamal & Wendy Stead. (2018) An opioid overdose curriculum for medical residents: Impact on naloxone prescribing, knowledge, and attitudes. Substance Abuse 39:3, pages 371-376.
Read now
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Robert Taylor$suffix/text()$suffix/text(), Jo Ann LeQuang & Robert B. Raffa. (2018) What’s holding back abuse-deterrent opioid formulations? Considering 12 U.S. stakeholders. Expert Opinion on Drug Delivery 15:6, pages 567-576.
Read now
Read now
Amy Bachyrycz, Shikhar Shrestha, Barry E. Bleske, Dale Tinker & Ludmila N. Bakhireva. (2017) Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery. Substance Abuse 38:1, pages 55-60.
Read now
Read now
Bryon Adinoff. (2016) The costs of prohibition. The American Journal of Drug and Alcohol Abuse 42:6, pages 621-623.
Read now
Read now
Articles from other publishers (6)
Rosanna Smart, Courtney A. Kase, Erin A. Taylor, Susan Lumsden, Scott R. Smith & Bradley D. Stein. (2020) Strengths and weaknesses of existing data sources to support research to address the opioids crisis. Preventive Medicine Reports 17, pages 101015.
Crossref
Crossref
Saumitra V. Rege, Duc Anh Ngo, Nassima Ait-Daoud, Sana Sharma, Evan Verplancken & Christopher P. Holstege. (2018) Trends and characteristics of naloxone therapy reported to US poison centers. Addiction 113:12, pages 2309-2315.
Crossref
Crossref
Heath B. McAnallyHeath B. McAnally. 2018. Opioid Dependence. Opioid Dependence
265
290
.
Nadia Fairbairn, Phillip O. Coffin & Alexander Y. Walley. (2017) Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic. International Journal of Drug Policy 46, pages 172-179.
Crossref
Crossref
Rachel Faulkner-Gurstein. (2017) The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy. Social Science & Medicine 180, pages 20-27.
Crossref
Crossref
Joji Suzuki & Saria El-Haddad. (2017) A review: Fentanyl and non-pharmaceutical fentanyls. Drug and Alcohol Dependence 171, pages 107-116.
Crossref
Crossref